In focus · trending topic

cancer treatment and outcomes

1 stories · following the connections

Guardant Health® and COTA Partner to Explore the Costs, Benefits, and Barriers of Genotyping Patients with Advanced Lung Cancer with a Non-invasive Liquid Biopsy

By Nasdaq OMXMar 15, 2016, 5:22 PM UTC